Food Pharmaceutical Peony Market Size, Share, and Forecast Analysis

The global food pharmaceutical peony market size reached at USD 126.45 million in 2025 and is predicted to increase from USD 142.76 million in 2026 to reach approximately USD 425.46 million by 2035, growing at a CAGR of 12.9% during the forecast period 2026 to 2035. Rising demand for the plant-based food and pharmaceuticals, changing consumer preference and technological development significantly driving the market.

Key Takeaways

• By region, Asia Pacific dominated the global market with the largest share of 61% in 2025. Cultural knowledge, along with rising disposable incomes and a trend towards comprehensive health methods, drives the demand for peony-based products.
• By region, North America is expected to grow at a notable CAGR from 2026 to 2035. The North America food pharmaceutical peony market is highly significant due to the rising requirement for natural and herbal components in the health and wellness sector. 
• By product type, peony root extracts segment held the major market share of 46% in 2025. This extract is a key component in both traditional and herbal medicine, utilized to reduce pain and inflammation linked to arthritis and menstrual discomfort.
• By product type, peony-infused functional foods segment is expected to grow at a CAGR in between 2026 and 2035. Increasing health awareness and a preventive healthcare trend, where consumers seek foods offering additional health benefits beyond basic nutrition rising the demand. 
• By compound focus, paeoniflorin-based products segment contributed the biggest market share of 38% in 2025. The increasing acknowledgment of this bioactive compound sourced from peony roots for its multiple health advantages.
• By compound focus, polyphenols & flavonoids segment is expanding at a significant CAGR in between 2026 and 2035. Increasing consumer demand for natural and plant-derived products for disease prevention and general health is a significant influence. 
• By application, nutraceuticals and supplements segment dominated the market with share of 42% in 2025. Increasing need for nutrient-dense foods driven by busy lifestyles and heightened consumer knowledge of the health benefits of these products is anticipated to propel market expansion.
• By application, skincare and natural cosmetics segment is expected to grow at a significant CAGR over the projected period. Growing worries about skin care stemming from various issues like acne, dark spots, scars, lack of radiance, and tanning have heightened the need for skin nourishment products.
• By end user, pharmaceuticals segment held the largest market share of 40% in 2025. Peony has been historically utilized in Chinese medicine for its properties that reduce inflammation, combat oxidation, and enhance immune function and therefore, widely used in the pharmaceuticals. 
• By end user, food & beverage segment is expected to grow at a CAGR in between 2026 and 2035. The worldwide trend towards health and wellness is another significant factor propelling the food and beverages industry.
• By distribution channel, pharmacies & herbal retailers segment contributed the biggest market share of 35% in 2025. The trust and reliability linked to buying health products from pharmacies strengthen their market standing.
• By distribution channel, online & direct-to-consumer channels segment is expanding at a significant CAGR in between 2026 and 2035. The online and direct-to-consumer (DTC) channel is an expanding pathway for the food pharmaceutical peony sector, providing enhanced accessibility and direct interaction with customers. 

Food Pharmaceutical Peony Industry Coverage

Market Overview

Inclination Towards the Herbal and Natural Alternative Accelerate the Market Demand

The food pharmaceutical peony market refers to the global industry involved in the cultivation, extraction, processing, and commercialization of peony plant derivatives particularly from the roots, seeds, and flowers used in functional food, nutraceuticals, and pharmaceutical applications. Peony (especially Paeonia lactiflora and Paeonia suffruticosa) contains bioactive compounds such as paeoniflorin, flavonoids, and polyphenols, known for their anti-inflammatory, antioxidant, immune-modulating, and neuroprotective properties. The market includes a variety of end uses in herbal medicine, supplements, healthy food, and natural cosmetics. 

What are the Key Trends in the Food Pharmaceutical Peony Market?

• A global trend is emerging that favors natural ingredients, as consumers are more frequently pursuing products that feature clean labels and transparency. Peony, recognized for its customary role in herbal medicine, is ideally suited to capitalize on this trend, especially in the food and drug industries. 
• The market is witnessing a shift towards customized health products, as consumers look for solutions tailored to their specific requirements. Peony's ability to tackle diverse health issues renders it a fitting choice for incorporation into these products. 
• The interest in functional foods and drinks has notably risen due to socioeconomic shifts, especially in health awareness to boost their effectiveness. Botanically derived functional ingredients are extensively utilized due to their health-promoting phytochemical properties. 
• For instance, it is estimated that about 80% of people globally utilize traditional medicine. As of now, 170 out of 194 WHO Member States have indicated the use of traditional medicine, and their governments have sought WHO’s assistance in establishing a credible foundation of evidence and data regarding traditional medicine practices and products. 
• Rising trends like the increasing inclination towards herbal treatments and sustainable sourcing methods are anticipated to enhance this market's reputation. Multiple elements, such as the growth of online retail for health goods and advancements in extraction methods, greatly impact market trends. 

Market Opportunity

Product Diversification Expanding the Market

Rising consumer curiosity about natural components and the expanding recognition of peony's possible health advantages. Crucial sectors for expansion encompass functional foods, dietary supplements, and customized health products, while continuous studies underscore the medicinal benefits of peony. Creative product development, like producing functional foods enriched with peony extracts, offers further possibilities. Continued studies emphasizing the healing capabilities of peony reveal an obvious opportunity for growth and advancement, guaranteeing that this enduring plant remains successful in today's market.

Market Challenge 

Challenges Impeding the Growth of the Food Pharmaceutical Peony Market 

Disruptions in the supply chain, logistical issues, and workforce shortages have hindered peony farming, impacting both quality and volume. Limited worker availability and travel limitations have obstructed harvesting, resulting in production setbacks and higher expenses. Moreover, economic uncertainties have limited consumer expenditure on non-essential goods, impacting the demand for peony-based products in the food and pharmaceutical industries. 

Food Pharmaceutical Peony Market Regional Insights 

Asia Pacific Dominated the Food Pharmaceutical Peony Market in 2025

Peony has been historically utilized in Chinese medicine for its inflammation-reducing, oxidative stress-fighting, and immune-enhancing qualities. In Asia, especially in China and Japan, peonies have profound cultural importance and are widely grown for decorative reasons and traditional medicinal applications. This cultural knowledge, along with rising disposable incomes and a trend towards comprehensive health methods, drives the demand for peony-based products. Certain governments in the Asia Pacific area back herbal medicine, thus boosting the usage and need for peony extract. 

Asia Pacific Food Pharmaceutical Peony Market Size 2025 to 2035

The Asia Pacific food pharmaceutical peony market size was valued at USD 77.13 million in 2025 and is predicted to increase from USD 87.08 million in 2026 to reach approximately USD 261.66 million by 2035, growing at a CAGR of 12.99% during the forecast period 2026 to 2035.

The market for Chinese food pharmaceutical peony plays a major role worldwide, fueled by robust local demand and a deep-rooted history in traditional medicine. China's market supremacy stems from its vast peony cultivation and well-established methods for producing and using peony root bark extract. The growth of this market is driven by a rising awareness of natural health products and their uses in pharmaceuticals, cosmetics, and dietary supplements. 

• For instance, Heze, the biggest center for peony cultivation in China, has exported Chinese peony seed oil, cosmetics, and various products to over 30 countries and regions, achieving a total output that surpasses 13 billion yuan that is $1.78 billion. (Source: Floral Daily)

North America Expects the Significant Growth During the Forecast Period

The North America food pharmaceutical peony market is highly significant due to the rising requirement for natural and herbal components in the health and wellness sector. The market has gained momentum owing to increased consumer interest in plant-based remedies for a range of health issues, such as anxiety, joint discomfort, and aging skin. As the movement towards plant-based remedies grows, the market is expected to experience consistent expansion in the years ahead, fueled by wellness trends in North America.

An increasing demand for natural health alternatives, such as products derived from peony, is driving market expansion in U.S. The increasing awareness of the therapeutic benefits of peony, including its anti-inflammatory and antioxidant properties, is driving market acceptance. Efforts by the U.S. government to fund and support research in herbal medicine are aiding in the validation of peony for different therapies. The U.S. market plays a crucial role in the worldwide trend towards herbal and natural products, making peony a highly desirable ingredient globally.

Food Pharmaceutical Peony Market Segmental Insights

Product Type Insights

Food Pharmaceutical Peony Market Share, By Product Type, 2025 (%)

• Peony Root Extracts: Dominates with 46%, as it is the most widely used and valued form of peony for its health benefits and versatility in food and pharmaceutical applications.
• Peony Seed Oil: Represents 10%, with growing interest in its cosmetic and health benefits, but still a smaller segment compared to root extracts.
• Dried Peony Root (Raw Herb): Holds 5%, with limited use in its raw form, serving a niche market that prefers traditional herbal remedies.
• Peony Flower Extracts: Represents 5%, catering to a specialized market looking for floral extracts, but does not dominate the overall peony product market.
• Peony Powder (Food Grade & Pharmaceutical Grade): Has 5%, used for specific applications in both food and pharmaceuticals but does not dominate compared to other forms like root extracts.
• Peony Capsules & Tablets: Represents 5%, offering convenient dosage forms, but is a small portion of the market due to consumer preference for other formats.
• Peony-Infused Beverages & Functional Foods: The fastest-growing segment at 24%, driven by rising demand for functional foods and beverages with health benefits, though still smaller than root extracts.

Which Product Type Segment Dominated the Food Pharmaceutical Peony Market in 2025?

Peony root extract segment dominated the market with the largest share in 2025. Peony root extract, obtained from the root bark of the peony plant, is well-known for its therapeutic benefits. The extraction method focuses on its bioactive compounds, which have anti-inflammatory, antioxidant, and pain-relieving properties. This extract is a key component in both traditional and herbal medicine, utilized to reduce pain and inflammation linked to arthritis and menstrual discomfort. Peony root extract is widely used in skincare items due to its effectiveness in calming irritated skin and diminishing redness, making it a sought-after ingredient in cosmetic and topical products.

Peony-infused functional food segment is observed to grow at the fastest rate during the forecast period. Increasing health awareness and a preventive healthcare trend, where consumers seek foods offering additional health benefits beyond basic nutrition to manage their well-being proactively. Health-conscious consumers are actively seeking out functional food with specific health benefits, such as those offered by herbal ingredients.

Compound Focus Insights

Food Pharmaceutical Peony Market Share, By Compound Focus, 2025 (%)

• Paeoniflorin Concentrates: Dominates with 38%, as paeoniflorin is the key active compound in peony, valued for its therapeutic effects, making it the most widely used compound.
• Polyphenols & Flavonoids: The fastest-growing segment at 24%, with increasing interest in antioxidant-rich compounds, although still a smaller share compared to paeoniflorin.
• Essential Oils: Represents 10%, used in both the cosmetic and pharmaceutical industries but not dominating due to its more niche applications.
• Tannins: Holds 5%, with limited applications in comparison to other compounds like paeoniflorin, contributing minimally to the overall market.
• Alkaloids & Glycosides: Represents 10%, offering specific benefits, but not dominating the market compared to the more widely used compounds.
• Anthocyanins: Holds 13%, valued for their antioxidant properties, but does not dominate compared to paeoniflorin and other more popular compounds.

Which Compound Focus Segment Held the Largest Share of the Food Pharmaceutical Peony Market in 2025?

Paeoniflorin-based products segment held the largest share of the market in 2025. The paeoniflorin-based products segment is a developing area in the herbal and pharmaceutical fields, marked by the increasing acknowledgment of this bioactive compound sourced from peony roots for its multiple health advantages. Paeoniflorin, recognized for its anti-inflammatory, pain-relieving, and neuroprotective effects, has captured interest in both conventional and contemporary medicine. Its uses extend to dietary supplements, beauty products, and medications, targeting various health concerns like persistent pain, anxiety, and dermatological issues. With the movement in healthcare towards natural and plant-derived options, the need for Paeoniflorin is anticipated to increase, providing various advantages while addressing the growing consumer inclination for holistic health solutions.

Flavonoid & Polyphenol Extracts Segment is Seen to Grow at a Notable Rate During the Predicted Timeframe

Increasing consumer demand for natural and plant-derived products for disease prevention and general health is a significant influence. Polyphenols are progressively being added to functional foods and drinks to improve their nutritional benefits and attractiveness. The interest in polyphenol-rich supplements is increasing, as people aim to tackle particular health issues or boost their daily nutrient consumption. The pharmaceutical and nutraceutical sectors are progressively utilizing plant flavonoids due to their potential health advantages. Consequently, the rising consumer demand for nutraceuticals is propelling the segment. 

Application Insights

Food Pharmaceutical Peony Market Share, By Application, 2025 (%)

• Functional Foods & Beverages: Represents 15%, with moderate demand, but does not dominate compared to nutraceuticals, which are the largest application for peony-based products.
• Nutraceuticals & Dietary Supplements: Dominates with 42%, as peony is widely used in nutraceuticals for its health benefits, securing the largest share of the market.
• Traditional Chinese Medicine (TCM) Formulations: Has 5%, catering to a niche market of traditional herbal practitioners, but does not dominate the broader market.
• Pharmaceutical Products: Represents 10%, with moderate adoption in pharmaceuticals but not dominating compared to nutraceuticals and functional foods.
• Skincare & Cosmetic Formulations: The fastest-growing segment at 8%, driven by the increasing use of peony extracts in skincare, though still a smaller share compared to other applications.
• Veterinary Health Products: Represents 5%, serving a niche market in veterinary health, but does not dominate the broader peony-based market.

Why did the Nutraceuticals & Supplements Segment Dominate the Food Pharmaceutical Peony Market in 2025?

Nutraceuticals & supplements segment led the food pharmaceutical peony market in 2025. Increasing need for nutrient-dense foods driven by busy lifestyles and heightened consumer knowledge of the health benefits of these products is anticipated to propel market expansion. Additionally, throughout the COVID-19 pandemic, a growingly anxious population turned to numerous nutraceuticals and supplements items that claimed to enhance immunity or offer protection against diseases. Such a trend is expected to drive the market in the years ahead. The worldwide nutraceuticals and supplements provide products for various application areas such as sports nutrition, clinical nutrition, weight management, heart health, immunity, and digestive health. Peony seeds and even leaves are being investigated for their nutritional and therapeutic benefits, presenting multiple possibilities for nutraceuticals and supplements developments. 

Skincare & Natural Cosmetics Segment is Expected to Grow at the Fastest Rate in the Market During the Forecast Period

The need for skin nutrition products has increased due to growing concerns about skin care caused by a variety of problems, including dark spots, acne, scars, lack of radiance, and tanning. Younger people are becoming more and more interested in skin-brightening creams, toners, and scrubs. On the other hand, because older people are becoming more demanding, the market for products that treat wrinkles or damaged heels is expanding significantly. Because of their potent anti-inflammatory, hydrating, and antioxidant properties, peony extracts particularly those from the white peony are becoming more and more popular in skincare and cosmetics products. They reduce wrinkles, soothe sensitive skin, and improve skin tone.

End User Insights

Food Pharmaceutical Peony Market Share, By End User, 2025 (%)

• Pharmaceuticals: Dominates with 40%, as the pharmaceutical industry is a major consumer of peony extracts for therapeutic uses, making it the largest end-user sector.
• Food & Beverage: The fastest-growing segment at 10%, driven by the rise of functional foods, but still smaller compared to pharmaceuticals.
• Nutraceuticals: Represents 15%, with steady demand for peony in dietary supplements, but not dominating compared to the pharmaceutical sector.
• Cosmetics & Personal Care: Has 10%, with growing use of peony extracts in personal care products, but does not dominate compared to pharmaceuticals and nutraceuticals.
• Veterinary & Animal Health: Represents 5%, with a niche market in veterinary health, but does not dominate compared to human-focused industries.
• Herbal & Traditional Medicine Practitioners: Represents 10%, serving a specific market of herbal practitioners, but does not dominate compared to more mainstream sectors like pharmaceuticals.

Which End User Segment Held the Dominating Share of the Food Pharmaceutical Peony Market in 2025?

Pharmaceuticals segment held the dominating share of the food pharmaceutical peony market in 2025. Peony has been historically utilized in Chinese medicine for its properties that reduce inflammation, combat oxidation, and enhance immune function. This has resulted in a greater integration of peony extracts into different pharmaceutical formulations and nutraceutical products. Moreover, the increasing prevalence of chronic illnesses and the worldwide aging demographic are fueling the need for natural and effective treatment options, which further supports market expansion.

Food and Beverage Segment is Observed to Grow at the Fastest CAGR During the Forecast Period

The worldwide trend towards health and wellness is another significant factor propelling the food and beverages industry. Shoppers are progressively focusing on items that support a healthier way of living, such as organic, plant-derived, and clean-label food choices. Furthermore, the growth of e-commerce provides a major chance for brands to connect with consumers directly, delivering tailored shopping experiences that accommodate personal dietary needs and limitations. Peony completes the consumer demand for the healthy and functional food and boosts the market. 

Distribution Channel Insights

Which Distribution Channel Dominated the Food Pharmaceutical Peony Market with the Largest Share in 2025?

Pharmacies & herbal retailers segment led the market with the largest share in 2025. Pharmacies and herbal stores remain an essential distribution channel, particularly for peony products utilized in dietary supplements and medications. The trust and reliability linked to buying health products from pharmacies strengthen their market standing. Customers frequently depend on pharmacists' knowledge to assist them in choosing suitable products, highlighting the significance of this avenue.

Online & Direct-to-consumer (DTC) Channels are Seen to Grow at a Notable Rate During the Predicted Timeframe

The online and direct-to-consumer (DTC) channel is an expanding pathway for the food pharmaceutical peony sector, providing enhanced accessibility and direct interaction with customers. This method enables businesses to avoid conventional intermediaries, which may reduce expenses and increase profits while also improving the customer experience. The online retail sector represents a crucial aspect of the DTC channel, enabling consumers to buy peony-based items straight from brand websites, online marketplaces, or dedicated e-commerce platforms.

Recent Developments in the Food Pharmaceutical Peony Market 

Peking University

• Research: In April 2025, researchers from Peking University, MCL Skincare, and Hangzhou Shiguang Xinya Biotechnology conducted human and laboratory studies to investigate whether peony callus extract could alleviate skin inflammation resulting from UVB exposure, as well as aid in repairing DNA damage and diminishing signs of skin aging. (Source: Cosmetics Design Asia)

Ichimaru Pharcos

• Launch: In May 2025, Ichimaru Pharcos, a Japanese manufacturer of cosmetic ingredients, unveiled PeoGlow, an active for skin tone sourced from an extract of peony roots. PeoGlow minimizes the buildup of advanced glycation endproducts (AGEs) and obstructs the interaction between AGEs and their receptors (RAGE), promoting a smoother, more luminous skin complexion. (Source: Personal Care Magazine)

Food Pharmaceutical Peony Market Leading Companies

• Shaanxi Yongyuan Bio-Tech Co., Ltd.
• Xi'an Greena Biotech Co., Ltd.
• Nutra Green Biotechnology Co., Ltd.
• io Botanica, Inc.
• Martin Bauer Group 
• Xi’an Sost Biotech Co., Ltd. 
• Naturalin Bio-Resources Co., Ltd. 
• Pure Encapsulations (Nestlé Health Science) 
• NOW Foods
• Gaia Herbs 
• Eu Yan Sang International Ltd. 
• Traditional Medicinals, Inc. 
• HerbaKraft Inc. 
• JIAHERB Inc. 
• Xi'an Rainbow Biotech Co., Ltd. 
• Himalaya Wellness Company 
• Nature’s Way Products, LLC 
• Blackmores Limited 
• Guangdong Yifang Pharmaceutical Co., Ltd. 
• Yunnan Baiyao Group Co., Ltd. 

Segments Covered in the Report

By Product Type

• Peony Root Extracts 
• Peony Seed Oil 
• Dried Peony Root (Raw Herb) 
• Peony Flower Extracts 
• Peony Powder (Food Grade & Pharmaceutical Grade) 
• Peony Capsules & Tablets 
• Peony-Infused Beverages & Functional Foods 

By Compound Focus

• Paeoniflorin Concentrates 
• Polyphenols & Flavonoids 
• Essential Oils 
• Tannins 
• Alkaloids & Glycosides 
• Anthocyanins 

By Application 

• Functional Foods & Beverages 
• Nutraceuticals & Dietary Supplements 
• Traditional Chinese Medicine (TCM) Formulations 
• Pharmaceutical Products 
• Skincare & Cosmetic Formulations 
• Veterinary Health Products

By End-User Industry 

• Pharmaceuticals 
• Food & Beverage 
• Nutraceuticals 
• Cosmetics & Personal Care 
• Veterinary & Animal Health 
• Herbal & Traditional Medicine Practitioners 

By Distribution Channel 

• Herbal Product Retailers 
• Pharmacies & Drugstores 
• Health Food Stores 
• Online Platforms & E-commerce 
• Direct-to-Consumer (DTC) 
• Export Channels (mainly Asia-Pacific to global markets)

By Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa (MEA)
• Latin America